Publications
2 shownDurvalumab plus platinum–etoposide versus platinum–etoposide in first-line treatment of extensive-stage small-cell lung cancer (CASPIAN): a randomised, controlled, open-label, phase 3 trial
Most patients with small-cell lung cancer (SCLC) have extensive-stage disease at presentation, and prognosis remains poor. Recently, immunotherapy has demonstrated clinical acti...
Frequent Co-Authors
Researcher Info
- h-index
- 2
- Publications
- 2
- Citations
- 2,212
- Institution
- The University of Texas Health Science Center at San Antonio
External Links
Identifiers
- ORCID
- 0000-0003-3094-9711
Impact Metrics
h-index
2
h-index: Number of publications with at least h citations each.